A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus GnP as First-Line Treatment for Patients With Recurrent or Metastatic Pancreatic Cancer (WGOG-PAN 006/ICSBR-2)
Clinical trial NCT07336953 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07336953
- Sponsor
- West China Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2027-07-01
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.